CMC Microsystems
Hurry, get your tickets today!
Details Here

Stéphane Gagné

President & CEO

Ovensa Inc.

Mr. Stéphane Gagné cumulates 25 years of experience in the fields of cosmetics, nutritional supplements, pharmaceutical products and active ingredients. He holds two bachelor’s degrees, one in economics, the other is multidisciplinary, as well as a master’s in business administration. Since 2006, Mr. Gagné co-founded 4 companies where he held the role of President & CEO. He is currently the CEO of Ovensa Inc., a company developing drug delivery platforms allowing novel drugs, such as RNA therapeutics, to reach their targets more efficiently. Before starting his companies, Mr. Gagné played a significant role in the growth of several Canadian companies abroad through his international network of contacts and business acumen. He held senior positions in biotech, cosmetic and supplement companies, one being Atrium Innovations where he was VP Sales & Marketing from its inception in 1999. Atrium was acquired by Nestlé in 2017 for 2.3 billion USD. Mr. Gagné has also been a consultant for Canadian and foreign companies looking to register their Site Licence and products with the Non-prescription and Natural Products Directorate of Health Canada as well as meeting the requirements of the US FDA. Mr. Gagné volunteers for not-for-profit organizations and likes to support other entrepreneurs. He volunteered as a mentor for a number of start-ups from Cohort 1, 2 and 3 of District Ventures, a business accelerator based in Calgary for health-related companies.

Sessions Stéphane Gagné is a part of

Wednesday, June 8, 2022

Health and Safety Session

2:00 pm to 3:30 pm
in Salon 11

Talk Description

FDA Guidance and Lessons learned in developing nanomaterials for health purposes

I will be covering the highlights of the latest guidance document from the FDA on drugs containing nanomaterials and some lessons learned over the past years in developing nanoparticles for biotech and pharmaceutical companies.

© 2024 NanoCanada. All rights reserved.

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram